Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Empagliflozin Tablets

Approval Number

国药准字H20249837

Company惠升生物制药股份有限公司

Registration Date

December 25, 2024

Drug Information

Generic Name

恩格列净片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

December 25, 2024

Company Information

Applicant Company

Company Name惠升生物制药股份有限公司

Company Address

吉林省梅河口市爱民东大街1088号

Manufacturing Company

Company Name南京海纳制药有限公司

Company Address

南京市江北新区科创大道 18 号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy